What are InfuSystem Holdings's total assets?

InfuSystem Holdings (INFU) holds $98.7M in total assets, down 5.4% year over year.

How much debt does InfuSystem Holdings have?

InfuSystem Holdings carries $24.1M in total debt against $58.7M of shareholders' equity, a debt-to-equity ratio of 0.41.

How much cash does InfuSystem Holdings have?

InfuSystem Holdings holds $2.1M in cash and equivalents.

Can InfuSystem Holdings cover its short-term obligations?

Its current ratio is 2.14 — current assets exceed current liabilities.

Where does InfuSystem Holdings's balance sheet data come from?

Every line is extracted from InfuSystem Holdings's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

InfuSystem Holdings INFU Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Cash and cash equivalents	$3.19M+505%	$527K+128%	$231K+40.0%	$165K-11.3%
Accounts receivable, net	$22.9M+8.0%	$21.2M+6.9%	$19.83M+17.5%	$16.87M+9.5%
Inventories	$5.39M-17.4%	$6.53M+2.0%	$6.4M+32.8%	$4.82M+22.4%
Prepaid expenses and other current assets	$4.86M+22.8%	$3.96M-4.9%	$4.16M+42.3%	$2.92M+15.3%
Total current assets	$36.34M+13.0%	$32.17M+5.0%	$30.62M+23.6%	$24.78M+12.3%
Property and equipment, net	$3.36M-16.7%	$4.03M-6.7%	$4.32M-1.5%	$4.39M-3.1%
Accumulated depreciation	$8.16M+14.2%	$7.15M+20.2%	$5.95M+21.1%	$4.91M+27.8%
Operating lease right-of-use assets	417,800,000%-119,600,000%	537,400,000%-132,900,000%	670,300,000%+253,500,000%	416,800,000%-7,300,000%
Goodwill	$3.71M0.0%	$3.71M0.0%	$3.71M0.0%	$3.71M0.0%
Intangible assets, net	$6.87M+6.4%	$6.46M-13.3%	$7.45M-11.7%	$8.44M-22.8%
Deferred tax assets	$4.64M-35.4%	$7.19M-21.1%	$9.12M-5.3%	$9.63M-4.1%
Other non-current assets	$1.68M+91.1%	$878K-44.5%	$1.58M+1,876%	$80K-31.0%
Total assets	$100.56M-2.9%	$103.61M+0.7%	$102.92M+3.5%	$99.39M+1.8%
Accounts payable	$10.82M+9.9%	$9.85M+23.0%	$8.01M-4.0%	$8.34M+6.1%
Accrued expenses	$9.36M+19.8%	$7.81M+1.4%	$7.7M+25.8%	$6.13M+30.8%
Current portion of long-term debt	$0—	$0—	$0—	$0-100%
Operating lease liabilities, current	$4.82M-20.3%	$6.04M-17.0%	$7.27M+55.0%	$4.69M+0.5%
Total current liabilities	$20.18M+14.3%	$17.66M+12.4%	$15.71M+8.6%	$14.47M+12.2%
Long-term debt	$19.63M-17.8%	$23.86M-18.0%	$29.1M-12.2%	$33.16M+1.2%
Operating lease liabilities, non-current	$3.43M-24.8%	$4.56M-21.4%	$5.8M+54.2%	$3.76M+2.5%
Operating Lease Liabilities (Total)	$4.82M-20.3%	$6.04M-17.0%	$7.27M+55.0%	$4.69M+0.5%
Total liabilities	$43.23M-6.2%	$46.09M-8.9%	$50.61M-1.5%	$51.39M+4.2%
Preferred stock	$0—	$0—	$0—	$0—
Common stock	200M+9,999,900%	2K0.0%	2K0.0%	2K0.0%
Additional paid-in capital	$117.46M+3.2%	$113.87M+3.7%	$109.84M+3.8%	$105.86M+3.9%
Retained earnings	-$60.7M-5.6%	-$57.46M+2.0%	-$58.63M+1.2%	-$59.34M-10.1%
Accumulated other comprehensive income (loss)	$565K-49.5%	$1.12M+2.8%	$1.09M-26.9%	$1.49M+456%
Total stockholders' equity	$57.33M-0.4%	$57.53M+10.0%	$52.3M+9.0%	$48M-0.6%
Total liabilities and stockholders' equity	$100.56M-2.9%	$103.61M+0.7%	$102.92M+3.5%	$99.39M+1.8%
Allowance for Doubtful Accounts	$300K—	——	——	——
Allowance for Doubtful Accounts Receivable (Current)	$300K—	——	——	——
Other current assets	$4.86M+22.8%	$3.96M-4.9%	$4.16M+42.3%	$2.92M+15.3%
Derivative Assets - Fair Value	$748K-49.5%	$1.48M+2.7%	$1.44M-26.6%	$1.97M+454%
Financing Receivables	——	——	——	——
Gross Lease Receivables	$1.91M-1.5%	$1.93M-25.1%	$2.58M—	——
Lease Receivable Payments - 2022 (Lessor)	——	——	——	——
Lease Receivable Payments - 2023 (Lessor)	——	——	——	——
Lease Receivable Payments - 2024 (Lessor)	——	——	——	——
Lease Receivable Payments - 2025 (Lessor)	——	——	——	——
Lease Receivable Payments - Remainder of Fiscal Year	——	——	——	——
Total Lease Receivable Payments	——	——	——	——
Lease Receivable Payments - Due Year Two	——	——	——	——
Lease Receivable Payments - Due Year Three	——	——	——	——
Lease Receivable Payments - Due Year Four	——	——	——	——
Lease Receivable - Undiscounted Excess Amount	——	——	——	——
Deferred Tax Assets and Other Non-Current Assets	$1.68M+91.1%	$878K-44.5%	$1.58M+1,876%	$80K-31.0%
Derivative Assets, Non-Current	$748K-49.5%	$1.48M+2.7%	$1.44M-26.6%	$1.97M+454%
Finite-Lived Intangible Assets - Expected Amortization Expense (Year One)	——	——	——	——
Indefinite-Lived Intangible Assets	$2M0.0%	$2M0.0%	$2M0.0%	$2M0.0%
Indefinite-Lived Intangible Assets, Gross	$2M0.0%	$2M0.0%	$2M0.0%	$2M0.0%
Indefinite-Lived Research and Development Assets	$2M0.0%	$2M0.0%	$2M0.0%	$2M0.0%
Indefinite-Lived Trademarks	$2M0.0%	$2M0.0%	$2M0.0%	$2M0.0%
Intangible Assets Gross (Excluding Goodwill)	$53.9M+2.5%	$52.57M0.0%	$52.57M0.0%	$52.57M-2.3%
Lease Receivable Payments - 2026 (Lessor)	——	——	——	——
Lease Receivable Payments - 2027 (Lessor)	——	——	——	——
Lease Receivable Payments - 2028 (Lessor)	——	——	——	——
Long-term receivables, net	——	——	——	——
Net Investment in Lease	$1.91M-1.5%	$1.93M-25.1%	$2.58M-38.0%	$4.17M-1.7%
Deferred tax assets	$4.64M-35.4%	$7.19M-21.1%	$9.12M-5.3%	$9.63M-4.1%
Intangible assets — net	——	——	——	——
Other intangible assets—net	$6.87M+6.4%	$6.46M-13.3%	$7.45M-11.7%	$8.44M-22.8%
Medical equipment for sale or rental	$4.59M+45.4%	$3.16M+3.5%	$3.05M+9.3%	$2.79M+60.2%
Medical equipment in rental service, net of accumulated depreciation	$34.46M-12.0%	$39.18M+12.2%	$34.93M-11.5%	$39.45M-1.1%
Operating lease right-of-use assets	$4.18M-22.3%	$5.37M-19.8%	$6.7M+60.8%	$4.17M-1.7%
Other non-current assets	$1.68M+91.1%	$878K-44.5%	$1.58M+1,876%	$80K-31.0%
Property, plant and equipment at cost	$11.52M+3.1%	$11.18M+8.9%	$10.27M+10.5%	$9.3M+11.1%
Operating Lease Right-of-Use Assets in Other Assets	$4.18M-22.3%	$5.37M-19.8%	$6.7M+60.8%	$4.17M-1.7%
Software and Technology Licenses, Net	$1.68M+91.1%	$878K-44.5%	$1.58M+1,876%	$80K-31.0%
Other accrued liabilities	$9.36M+19.8%	$7.81M+1.4%	$7.7M+25.8%	$6.13M+30.8%
Finance Lease Liability Payments Due	——	——	——	——
Lease Liability Payments - 2020 (Remaining Three Months)	——	——	——	——
Operating Lease Liability Payments - 2024 (Lessee)	——	——	——	——
Operating Lease Liability Payments - 2025 (Lessee)	——	——	——	——
Lease Liability Payments - Due Year Two	——	——	——	——
Lease Liability Payments - Due Year Three	——	——	——	——
Lease Liability Payments - Due Year Four	——	——	——	——
Lease Liability Payments - Remainder of Fiscal Year	——	——	——	——
Lease Liability - Undiscounted Excess Amount	——	——	——	——
Operating Lease Liability Payments Due	——	——	——	——
Operating Lease Liability - Undiscounted Excess Amount	——	——	——	——
Debt Maturity - 2024	——	——	——	——
Debt Maturity - 2027	——	——	——	——
Debt - Unamortized Discount (Premium) and Issuance Costs, Net	$375K+44.2%	$260K-23.1%	$338K+48.9%	$227K-24.3%
Operating Lease Liability Payments - 2026 (Lessee)	——	——	——	——
Operating Lease Liability Payments - 2027 (Lessee)	——	——	——	——
Operating Lease Liability Payments - 2028 (Lessee)	——	——	——	——
Total debt	$24.44M-18.3%	$29.9M-17.8%	$36.37M-3.9%	$37.85M+0.2%
Total Carrying Value of Debt	——	——	——	——
Common Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Common Stock Shares Issued	20.2M-5.0%	21.3M+0.4%	21.2M+2.0%	20.8M+0.4%
Convertible Preferred Stock Authorized Shares	1M0.0%	1M0.0%	1M0.0%	1M0.0%
Convertible Preferred Stock Issued Shares	0—	0—	0—	0—
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$2K0.0%	$2K0.0%	$2K0.0%	$2K0.0%
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding	$0—	$0—	$0—	$0—
Preferred Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Share Repurchase Authorization Limit	——	——	——	——
Cumulative Cost Basis	$11.52M+3.1%	$11.18M+8.9%	$10.27M+10.5%	$9.3M+11.1%
Allowance for doubtful accounts	$300K—	——	——	——
Common stock, par value (in dollars per share)	$00.0%	$00.0%	$00.0%	$00.0%
Common stock, shares authorized (in shares)	$200M0.0%	$200M0.0%	$200M0.0%	$200M0.0%
Common stock, shares issued (in shares)	$20.21M-5.0%	$21.27M+0.4%	$21.2M+2.0%	$20.78M+0.4%
Common Stock, Shares, Outstanding	$20.21M-5.0%	$21.27M+0.4%	$21.2M+2.0%	$20.78M+0.4%
Contract assets	$1.24M+107%	$600K-52.8%	$1.27M—	——
Contract liabilities	$109K—	$0—	——	——
Long-term debt, gross	——	——	——	——
Derivatives	$748K-49.5%	$1.48M+2.7%	$1.44M-26.6%	$1.97M+454%
2031 and thereafter	——	——	——	——
Finite-Lived Intangible Assets, Accumulated Amortization	$47.04M+2.0%	$46.12M+2.2%	$45.13M+2.2%	$44.14M+2.9%
2028	——	——	——	——
2030	——	——	——	——
Remainder of 2026	——	——	——	——
2027	——	——	——	——
2029	——	——	——	——
Trademarks	$2M0.0%	$2M0.0%	$2M0.0%	$2M0.0%
Indefinite- lived intangible impairment	$53.9M+2.5%	$52.57M0.0%	$52.57M0.0%	$52.57M-2.3%
Lessee Operating Lease Liability Payments Due	——	——	——	——
2031 and thereafter	——	——	——	——
Lessee Operating Lease Liability Undiscounted Excess Amount	——	——	——	——
2030 and thereafter	——	——	——	——
2028	——	——	——	——
2029	——	——	——	——
2027	——	——	——	——
Remainder of 2026	——	——	——	——
Medical equipment for sale or rental	$4.6M+44.6%	$3.18M+3.3%	$3.08M+10.0%	$2.8M+56.7%
Medical Equipment Held For Sale Or Rental, Reserve	$11K-56.0%	$25K—	——	——
Medical Equipment In Rental Services, Accumulated Depreciation	$71.88M+10.0%	$65.32M+10.3%	$59.24M+3.1%	$57.44M+12.8%
Medical Equipment In Rental Services Gross	$109.06M+1.9%	$107.03M+11.1%	$96.3M-2.9%	$99.16M+7.9%
Medical Equipment In Rental Services, Reserve	$2.73M+7.8%	$2.53M+19.0%	$2.13M-6.3%	$2.27M+111%
Medical Equipment Net	$39.05M-7.8%	$42.33M+11.5%	$37.98M-10.1%	$42.24M+1.5%
Operating Lease Weighted Average Discount Rate Percent	——	——	——	——
Preferred Stock, Par or Stated Value Per Share	$00.0%	$00.0%	$00.0%	$00.0%
Preferred Stock, Shares Authorized	$1M0.0%	$1M0.0%	$1M0.0%	$1M0.0%
Preferred Stock, Shares Issued	$0—	$0—	$0—	$0—
2028	——	——	——	——
2030	——	——	——	——
Sales-Type and Direct Financing Leases, Payment to be Received	——	——	——	——
Remainder of 2026	——	——	——	——
2027	——	——	——	——
2029	——	——	——	——
Thereafter	——	——	——	——
Sales-type lease, lease receivable	$1.91M-1.5%	$1.93M-25.1%	$2.58M—	——
Sales-Type Lease, Net Investment in Lease, before Allowance for Credit Loss	$1.91M-1.5%	$1.93M-25.1%	$2.58M—	——
Cumulative shares purchased (in shares)	——	——	——	——
Cumulative shares purchased	——	——	——	——
Share Repurchase Program, Authorized, Amount	——	——	——	——
Unamortized Debt Issuance Expense	$375K+44.2%	$260K-23.1%	$338K+48.9%	$227K-24.3%
Unamortized Debt Issuance Expense Current	$0—	$0—	$0—	$0-100%
Unamortized Debt Issuance Expense Noncurrent	$375K+44.2%	$260K-23.1%	$338K+48.9%	$227K+0.4%
Remainder of Fiscal Year 2024	——	——	——	——
Remainder of Fiscal Year 2025	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about InfuSystem Holdings.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are InfuSystem Holdings's total assets?: InfuSystem Holdings (INFU) holds $98.7M in total assets, down 5.4% year over year.
How much debt does InfuSystem Holdings have?: InfuSystem Holdings carries $24.1M in total debt against $58.7M of shareholders' equity, a debt-to-equity ratio of 0.41.
How much cash does InfuSystem Holdings have?: InfuSystem Holdings holds $2.1M in cash and equivalents.
Can InfuSystem Holdings cover its short-term obligations?: Its current ratio is 2.14 — current assets exceed current liabilities.
Where does InfuSystem Holdings's balance sheet data come from?: Every line is extracted from InfuSystem Holdings's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.